Stories > Otsuka's Phase 3 Trial Results

Otsuka's Phase 3 Trial Results

ABVC BioPharma's Patent and Partnership

Advancements in Psychiatric Treatments

Amneal Resubmits IPX203 for Parkinson’s ...

ANJESO Drug Insight and Market Forecast

AlzeCure's Drug Therapy Focus

Asia Pacific Epilepsy Therapeutic Market...